2016
DOI: 10.1136/tsaco-2016-000022
|View full text |Cite
|
Sign up to set email alerts
|

Surgeon's guide to anticoagulant and antiplatelet medications part two: antiplatelet agents and perioperative management of long-term anticoagulation

Abstract: An increasing number of potent antiplatelet and anticoagulant medications are being used for the long-term management of cardiac, cerebrovascular, and peripheral vascular conditions. Management of these medications in the perioperative and peri-injury settings can be challenging for surgeons, mandating an understanding of these agents and the risks and benefits of various management strategies. In this two part review, agents commonly encountered by surgeons in the perioperative and peri-injury settings are di… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(9 citation statements)
references
References 45 publications
(52 reference statements)
0
9
0
Order By: Relevance
“…This was perhaps due to the increased risk of bleeding such therapy poses. The use of anti-platelets alone has been associated with increasing the risk of post-traumatic bleeding and morbidity [ 29 , 30 ] and therefore, the risk is largely dependent on platelet function that is perhaps best assessed by determining overall clot strength through a whole blood assay [ 31 ]. In a time-restricted situation such as in traumatic vascular surgery, this can be a challenging feat.…”
Section: Discussionmentioning
confidence: 99%
“…This was perhaps due to the increased risk of bleeding such therapy poses. The use of anti-platelets alone has been associated with increasing the risk of post-traumatic bleeding and morbidity [ 29 , 30 ] and therefore, the risk is largely dependent on platelet function that is perhaps best assessed by determining overall clot strength through a whole blood assay [ 31 ]. In a time-restricted situation such as in traumatic vascular surgery, this can be a challenging feat.…”
Section: Discussionmentioning
confidence: 99%
“…In cases where the patient is at high risk for a thromboembolic episode, a "bridge"-a balance between surgical bleed and risk of thrombosis may be achieved either with intravenous unfractionated heparin or with subcutaneous lowmolecular-weight heparin [16].…”
Section: Bridging With Heparinmentioning
confidence: 99%
“…Antithrombotic therapy involves both antiplatelet and anticoagulation therapies. Although both antiplatelet and anticoagulation therapies have different mechanisms of action, they are vital to prevent further cardiovascular thrombotic events in high-risk patients; however, they also poses the risk of hemorrhage [1]. In these patients, surgeons should decide whether to continue these medications perioperatively, while considering the increased risk of bleeding and thrombotic events.…”
Section: Antithrombotic Therapymentioning
confidence: 99%